Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
175,611,455
-
Total 13F shares
-
137,614,303
-
Share change
-
-3,442,079
-
Total reported value
-
$3,492,597,576
-
Put/Call ratio
-
77%
-
Price per share
-
$25.35
-
Number of holders
-
408
-
Value change
-
-$105,102,768
-
Number of buys
-
152
-
Number of sells
-
246
Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) as of Q3 2022
As of 30 Sep 2022,
Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) was held by
408 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
137,614,303 shares.
The largest 10 holders included
ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, STATE OF MICHIGAN RETIREMENT SYSTEM, Kinnevik AB (publ), and RENAISSANCE TECHNOLOGIES LLC.
This page lists
417
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.